Hepatic ischaemia-reperfusion injury is the leading cause of early organ failure after transplant.
MCJ protein silencing emerges as a new therapy to prevent liver failure after ischaemia-reperfusion ...
Liver transplant is the only curative treatment for acute liver failure and end-stage liver disease. Since its main limitation is the scarcity of available organs, a major effort has been made in rece...
Individuals with alterations in magnesium levels have an increased risk of presenting fatty liver disease with inflammation and fibrosis, as concluded by a study that has just been published in Journa...
Joan Clària, head of the Inflammation on liver disease research group at IDIBAPS-Clínic, has been one of the winners of the Albus awards, given annually by the company Grifols. With an endowment of ...
Dr. Victor Puntes, head of the Design and Pharmacodynamics of Nanoparticles group at the CIBBIM- Nanomedicine, has recently published in the Journal of Hepatology a study about the benefits of cerium ...